RepliCel Historical Balance Sheet
RP Stock | CAD 0.01 0.01 50.00% |
Trend analysis of RepliCel Life Sciences balance sheet accounts such as Net Debt of 791.7 K, Accounts Payable of 472.3 K, Cash of 56.2 K or Non Current Assets Total of 119.4 K provides information on RepliCel Life's total assets, liabilities, and equity, which is the actual value of RepliCel Life Sciences to its prevalent stockholders. By breaking down trends over time using RepliCel Life balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining RepliCel Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether RepliCel Life Sciences is a good buy for the upcoming year.
RepliCel |
About RepliCel Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of RepliCel Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. RepliCel Life Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of RepliCel Life and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which RepliCel currently owns. An asset can also be divided into two categories, current and non-current.
RepliCel Life Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of RepliCel Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in RepliCel Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on RepliCel Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of RepliCel Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from RepliCel Life's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into RepliCel Life Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, RepliCel Life's Other Liabilities is fairly stable compared to the past year.
2021 | 2022 | 2023 | 2024 (projected) | |
Short and Long Term Debt Total | 34.3K | 41.0K | 813.2K | 487.3K |
Total Assets | 591.8K | 798.2K | 287.8K | 273.4K |
RepliCel Life balance sheet Correlations
Click cells to compare fundamentals
RepliCel Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
RepliCel Life balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 505.5K | 421.0K | 591.8K | 798.2K | 287.8K | 273.4K | |
Total Current Liabilities | 1.6M | 2.2M | 1.7M | 2.1M | 1.8M | 1.9M | |
Total Stockholder Equity | (4.4M) | (5.1M) | (6.8M) | (5.9M) | (4.5M) | (4.3M) | |
Property Plant And Equipment Net | 6.0K | 4.4K | 3.3K | 2.4K | 967.0 | 918.65 | |
Net Debt | 425.4K | 41.7K | (186.9K) | (372.1K) | 754.0K | 791.7K | |
Retained Earnings | (36.6M) | (38.2M) | (42.2M) | (43.0M) | (43.3M) | (41.1M) | |
Accounts Payable | 640.3K | 1.3M | 602.0K | 817.9K | 416.0K | 472.3K | |
Cash | 23.9K | 34.4K | 221.2K | 413.0K | 59.2K | 56.2K | |
Non Current Assets Total | 272.2K | 235.3K | 198.8K | 162.5K | 125.7K | 119.4K | |
Cash And Short Term Investments | 52.7K | 51.6K | 238.4K | 430.3K | 76.4K | 72.6K | |
Net Receivables | 51.9K | 63.6K | 61.2K | 82.2K | 38.0K | 39.0K | |
Common Stock Shares Outstanding | 24.1M | 27.0M | 32.5M | 37.8M | 59.2M | 62.2M | |
Liabilities And Stockholders Equity | 505.5K | 421.0K | 591.8K | 798.2K | 287.8K | 273.4K | |
Other Stockholder Equity | 4.6M | 4.6M | 5.1M | 5.4M | 5.6M | 5.6M | |
Total Liab | 4.9M | 5.5M | 7.4M | 6.7M | 4.8M | 5.1M | |
Total Current Assets | 233.2K | 185.7K | 393.0K | 635.7K | 162.1K | 154.0K | |
Short Term Debt | 449.3K | 47.3K | 611.4K | 689.3K | 813.2K | 853.8K | |
Common Stock | 27.5M | 28.5M | 30.3M | 31.7M | 33.1M | 20.0M | |
Other Current Liab | 107.3K | 517.8K | 106.6K | 211.8K | 239.5K | 432.0K | |
Other Assets | 266.2K | 230.8K | 195.5K | 1.0 | 1.15 | 1.09 | |
Non Current Liabilities Total | 3.4M | 3.2M | 5.8M | 4.6M | 3.0M | 2.1M | |
Other Current Assets | 128.7K | 70.5K | 93.4K | 123.2K | 47.7K | 89.2K | |
Net Tangible Assets | (1.9M) | (4.4M) | (5.1M) | (6.8M) | (6.2M) | (5.9M) | |
Property Plant Equipment | 8.2K | 6.0K | 4.4K | 3.3K | 2.9K | 2.8K | |
Net Invested Capital | (2.9M) | (5.0M) | (6.8M) | (5.9M) | (5.3M) | (5.6M) | |
Net Working Capital | (1.2M) | (2.1M) | (1.3M) | (1.4M) | (1.3M) | (1.4M) | |
Capital Stock | 29.0M | 28.5M | 30.3M | 31.7M | 36.4M | 32.6M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.